Respective Roles of CYP2A5 and CYP2F2 in the Bioactivation of 3-Methylindole in Mouse Olfactory Mucosa and Lung: Studies Using Cyp2a5-Null and Cyp2f2-Null Mouse Models

被引:13
|
作者
Zhou, Xin [1 ,2 ]
D'Agostino, Jaime [1 ,2 ]
Li, Lei [1 ,2 ]
Moore, Chad D. [3 ]
Yost, Garold S. [3 ]
Ding, Xinxin [1 ,2 ]
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Mol Toxicol Lab, Albany, NY 12201 USA
[2] SUNY Albany, Sch Publ Hlth, Albany, NY USA
[3] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
METABOLIC-ACTIVATION; DEHYDROGENATION; TOXICITY; 2,6-DICHLOROBENZONITRILE; BRONCHIOLAR; NAPHTHALENE; MECHANISMS; EXPRESSION; NECROSIS;
D O I
10.1124/dmd.111.044081
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to determine whether mouse CYP2A5 and CYP2F2 play critical roles in the bioactivation of 3-methylindole (3MI), a tissue-selective toxicant, in the target tissues, the nasal olfactory mucosa (OM) and lung. Five metabolites of 3MI were identified in NADPH- and GSH-fortified microsomal reactions, including 3-glutathionyl-S-methylindole (GS-A1), 3-methyl-2-glutathionyl-S-indole (GS-A2), 3-hydroxy-3-methyleneindolenine (HMI), indole-3-carbinol (I-3-C), and 3-methyloxindole (MOI). The metabolite profiles and enzyme kinetics of the reactions were compared between OM and lung, and among wild-type, Cyp2a5-null, and Cyp2f2-null mice. In lung reactions, GS-A1, GS-A2, and HMI were detected as major products, and I-3-C and MOI, as minor metabolites. In OM reactions, all five metabolites were detected in ample amounts. The loss of CYP2F2 affected formation of all 3MI metabolites in the lung and formation of HMI, GS-A1, and GS-A2 in the OM. In contrast, loss of CYP2A5 did not affect formation of 3MI metabolites in the lung but caused substantial decreases in I-3-C and MOI formation in the OM. Thus, whereas CYP2F2 plays a critical role in the 3MI metabolism in the lung, both CYP2A5 and CYP2F2 play important roles in 3MI metabolism in the OM. Furthermore, the fate of the reactive metabolites produced by the two enzymes through common dehydrogenation and epoxidation pathways seemed to differ with CYP2A5 supporting direct conversion to stable metabolites and CYP2F2 supporting further formation of reactive iminium ions. These results provide the basis for understanding the respective roles of CYP2A5 and CYP2F2 in 3MI's toxicity in the respiratory tract.
引用
收藏
页码:642 / 647
页数:6
相关论文
共 50 条
  • [21] Characterization of humanized liver from chimeric mice using coumarin as a human CYP2A6 and mouse CYP2A5 probe
    Aoki, Kimiko
    Kashiwagura, Yasuharu
    Horie, Toru
    Sato, Hitoshi
    Tateno, Chise
    Ozawa, Naoki
    Yoshizato, Katsutoshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (04) : 277 - 285
  • [22] Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments
    Shultz, MA
    Morin, D
    Chang, AM
    Buckpitt, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 296 (02): : 510 - 519
  • [23] Studies of styrene, styrene oxide and 4-hydroxystyrene toxicity in CYP2F2 knockout and CYP2F1 humanized mice support lack of human relevance for mouse lung tumors
    Cruzan, G.
    Bus, J.
    Hotchkiss, J.
    Sura, R.
    Moore, C.
    Yost, G.
    Banton, M.
    Sarang, S.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2013, 66 (01) : 24 - 29
  • [24] Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: Role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes
    Gu, J
    Zhang, QY
    Genter, MB
    Lipinskas, TW
    Negishi, M
    Nebert, DW
    Ding, XX
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 285 (03): : 1287 - 1295
  • [25] Role of CYP2A13 in NNK bioactivation and lung tumorigenesis: In vivo studies using a CYP2A13-humanized mouse model
    Megaraj, Vandana
    Zhou, Xin
    Liu, Zhihua
    Xie, Fang
    D'Agostino, Jaime
    Yang, Weizhu
    Ding, Xinxin
    CANCER RESEARCH, 2012, 72
  • [26] Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes
    Anneli Kojo
    Pirkko Viitala
    Markku Pasanen
    Olavi Pelkonen
    Hannu Raunio
    Risto Juvonen
    Archives of Toxicology, 1998, 72 : 336 - 341
  • [27] Ethanol Induction of CYP2A5: Role of CYP2E1-ROS-Nrf2 Pathway
    Lu, Yongke
    Zhang, Xu Hannah
    Cederbaum, Arthur I.
    TOXICOLOGICAL SCIENCES, 2012, 128 (02) : 427 - 438
  • [28] Bioactivation of 1,1-dichloroethylene by CYP2E1 and CYP2F in murine lung
    Forkert, PG
    Simmonds, AC
    Ghanayem, BI
    Sharma, A
    Reilly, CA
    Millen, B
    Yost, GS
    DRUG METABOLISM REVIEWS, 2004, 36 : 93 - 93
  • [29] Induction of CYP2A5 by pyrazole and its derivatives in mouse primary hepatocytes
    Kojo, A
    Viitala, P
    Pasanen, M
    Pelkonen, O
    Raunio, H
    Juvonen, R
    ARCHIVES OF TOXICOLOGY, 1998, 72 (06) : 336 - 341
  • [30] More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde
    Rahnasto, M
    Raunio, H
    Poso, A
    Juvonen, RO
    XENOBIOTICA, 2003, 33 (05) : 529 - 539